Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Ghana
Ghana: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 92.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Ghana, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Ghana stood at 92.0%. That is the highest value across all 26 years on record.
The figure is up 46.0% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Ghana peaked at 92.0% in 2024 and was at its lowest, 0.0%, in 2000.
Ghana ranks 56th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Ghana, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 52.0% | — |
| 2013 | 54.0% | +3.8% |
| 2014 | 67.0% | +24.1% |
| 2015 | 63.0% | -6.0% |
| 2016 | 75.0% | +19.0% |
| 2017 | 83.0% | +10.7% |
| 2018 | 83.0% | +0.0% |
| 2019 | 83.0% | +0.0% |
| 2020 | 79.0% | -4.8% |
| 2021 | 83.0% | +5.1% |
| 2022 | 84.0% | +1.2% |
| 2023 | 82.0% | -2.4% |
| 2024 | 92.0% | +12.2% |
| 2025 | 92.0% | +0.0% |
Ghana compared with similar countries
- Ghana's 92.0% is above the median for lower middle income countries, which is 70.0%, 1.3× the median. (47 countries reporting)
- Ghana's 92.0% is above the median for Sub-Saharan Africa, which is 66.0%, 1.4× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 56.0% | 0.0% | 83.0% | 10 |
| 2020s | 85.3% | 79.0% | 92.0% | 6 |
Countries ranked near Ghana
More health data for Ghana
- Un projection of annual infant deaths, annual growth rate -1.37 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6224 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 986.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,361 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 0.5623 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.06 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5816 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Ghana?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Ghana was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Ghana?
- The highest recorded value was 92.0% in 2024.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Ghana?
- The lowest recorded value was 0.0% in 2000.
- How does Ghana rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Ghana ranks 56th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Ghana?
- Over the last ten years it is up 46.0%. The long-run trend across the full record is volatile.
- Where does this Ghana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).